| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $157.7M | +26.6% |
| SG&A Expense | $21.0M | +18.4% |
| Operating Income | -$178.7M | -25.6% |
| Pre-tax Income | -$162.4M | -25.5% |
| Income Tax | $3K | +50.0% |
| Net Income | -$162.5M | -25.5% |
| EPS (Basic) | -$1.87 | +15.0% |
| EPS (Diluted) | -$1.87 | +15.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.3M | -65.4% |
| Short-term Investments | $457.1M | +55.2% |
| Current Assets | $515.5M | +17.6% |
| Total Assets | $533.4M | +18.3% |
| Current Liabilities | $51.8M | +24.1% |
| Total Liabilities | $54.9M | +30.6% |
| Stockholders' Equity | $478.6M | +17.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$146.7M | -40.6% |
| Capital Expenditures | $159K | +0.0% |
| Investing Cash Flow | -$155.8M | -66.5% |
| Financing Cash Flow | $211.3M | -21.4% |
| Free Cash Flow | -$146.9M | -40.5% |